{"pmid":32405842,"title":"[COVID-19 in older adults - a complex challenge].","text":["[COVID-19 in older adults - a complex challenge].","MMW Fortschr Med","Gosch, Markus","Singler, Katrin","Kwetkat, Anja","Heppner, Hans-Jurgen","32405842"],"journal":"MMW Fortschr Med","authors":["Gosch, Markus","Singler, Katrin","Kwetkat, Anja","Heppner, Hans-Jurgen"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405842","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s15006-020-0474-z","keywords":["covid-19","corona","sars-cov-2","older adults"],"weight":0,"_version_":1666802845604642816,"score":9.490897,"similar":[{"pmid":32255507,"title":"COVID-19 and Older Adults: What We Know.","text":["COVID-19 and Older Adults: What We Know.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel virus that causes COVID-19 infection, has recently emerged and caused a deadly pandemic. Studies have shown that this virus causes worse outcomes and a higher mortality rate in older adults and those with comorbidities such as hypertension, cardiovascular disease, diabetes, chronic respiratory disease, and chronic kidney disease (CKD). A significant percentage of older American adults have these diseases, putting them at a higher risk of infection. Additionally, many adults with hypertension, diabetes, and CKD are placed on angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers. Studies have shown that these medications upregulate the ACE-2 receptor, the very receptor that the SARS-CoV-2 virus uses to enter host cells. Although it has been hypothesized that this may cause a further increased risk of infection, more studies on the role of these medications in COVID-19 infections are necessary. In this review, we discuss the transmission, symptomatology, and mortality of COVID-19 as they relate to older adults, and possible treatments that are currently under investigation.","J Am Geriatr Soc","Shahid, Zainab","Kalayanamitra, Ricci","McClafferty, Brendan","Kepko, Douglas","Ramgobin, Devyani","Patel, Ravi","Aggarwal, Chander Shekher","Vunnam, Ramarao","Sahu, Nitasa","Bhatt, Dhirisha","Jones, Kirk","Golamari, Reshma","Jain, Rohit","32255507"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel virus that causes COVID-19 infection, has recently emerged and caused a deadly pandemic. Studies have shown that this virus causes worse outcomes and a higher mortality rate in older adults and those with comorbidities such as hypertension, cardiovascular disease, diabetes, chronic respiratory disease, and chronic kidney disease (CKD). A significant percentage of older American adults have these diseases, putting them at a higher risk of infection. Additionally, many adults with hypertension, diabetes, and CKD are placed on angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers. Studies have shown that these medications upregulate the ACE-2 receptor, the very receptor that the SARS-CoV-2 virus uses to enter host cells. Although it has been hypothesized that this may cause a further increased risk of infection, more studies on the role of these medications in COVID-19 infections are necessary. In this review, we discuss the transmission, symptomatology, and mortality of COVID-19 as they relate to older adults, and possible treatments that are currently under investigation."],"journal":"J Am Geriatr Soc","authors":["Shahid, Zainab","Kalayanamitra, Ricci","McClafferty, Brendan","Kepko, Douglas","Ramgobin, Devyani","Patel, Ravi","Aggarwal, Chander Shekher","Vunnam, Ramarao","Sahu, Nitasa","Bhatt, Dhirisha","Jones, Kirk","Golamari, Reshma","Jain, Rohit"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32255507","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1111/jgs.16472","keywords":["covid-19","sars-cov-2","coronavirus","mortality","older adults"],"locations":["American"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Transmission","Diagnosis","Treatment"],"weight":1,"_version_":1666138493168910336,"score":67.34102},{"pmid":32236694,"title":"[Geriatrics in times of corona].","text":["[Geriatrics in times of corona].","The current corona crisis affects older patients as well as the geriatric infrastructure in all sectors. This article provides an overview about the current state of knowledge on COVID-19 with special consideration of geriatric aspects and the consequences for the geriatric care system.","Z Gerontol Geriatr","Gosch, M","Singler, K","Kwetkat, A","Heppner, H J","32236694"],"abstract":["The current corona crisis affects older patients as well as the geriatric infrastructure in all sectors. This article provides an overview about the current state of knowledge on COVID-19 with special consideration of geriatric aspects and the consequences for the geriatric care system."],"journal":"Z Gerontol Geriatr","authors":["Gosch, M","Singler, K","Kwetkat, A","Heppner, H J"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32236694","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1007/s00391-020-01725-2","keywords":["covid-19","corona","older adults","sars-cov2"],"weight":0,"_version_":1666138490444709889,"score":61.47197},{"pmid":32412361,"title":"Service Needs of Older Adults with Serious Mental Illness.","text":["Service Needs of Older Adults with Serious Mental Illness.","The COVID-19 pandemic places older adults with serious mental illness with medical comorbidity at greater risk for poor physical and mental health outcomes. Social workers can play an important role in promoting well-being by working collaboratively with clients to address loneliness and to develop chronic disease self-management skills. Integration of physical and behavioral healthcare is even more essential now for promoting well-being among older adults with schizophrenia spectrum, bipolar, and major depressive disorders.","J Gerontol Soc Work","Dell, Nathaniel A","Sasaki, Natsuki","Stewart, Madeline","Murphy, Allison M","Klier, Marina","32412361"],"abstract":["The COVID-19 pandemic places older adults with serious mental illness with medical comorbidity at greater risk for poor physical and mental health outcomes. Social workers can play an important role in promoting well-being by working collaboratively with clients to address loneliness and to develop chronic disease self-management skills. Integration of physical and behavioral healthcare is even more essential now for promoting well-being among older adults with schizophrenia spectrum, bipolar, and major depressive disorders."],"journal":"J Gerontol Soc Work","authors":["Dell, Nathaniel A","Sasaki, Natsuki","Stewart, Madeline","Murphy, Allison M","Klier, Marina"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32412361","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1080/01634372.2020.1765064","keywords":["covid-19","healthcare integration","older adults","serious mental illness"],"weight":0,"_version_":1666897319230963713,"score":59.589096},{"pmid":32476586,"title":"Meeting the Transitional Care Needs of Older Adults with COVID-19.","text":["Meeting the Transitional Care Needs of Older Adults with COVID-19.","Older adults with COVID-19 who survive hospitalizations and return to their homes confront substantial health challenges and an unpredictable future. While understanding of the unique needs of COVID-19 survivors is developing, components of the evidence-based Transitional Care Model provide a framework for taking a more immediate, holistic response to caring for these individuals as they moved back into the community. These components include: increasing screening, building trusting relationships, improving patient engagement, promoting collaboration across care teams, undertaking symptom management, increasing family caregiver care/education, coordinating health and social services, and improving care continuity. Evidence generated from rigorous testing of these components reveal the need for federal and state policy solutions to support the following: employment/redeployment of nurses, social workers, and community health workers; training and reimbursement of family caregivers; widespread access to research-based transitional care tools; and coordinated local efforts to address structural barriers to effective transitions. Immediate action on these policy options is necessary to more effectively address the complex issues facing these older adults and their family caregivers who are counting on our care system for essential support.","J Aging Soc Policy","Naylor, Mary D","Hirschman, Karen B","McCauley, Kathleen","32476586"],"abstract":["Older adults with COVID-19 who survive hospitalizations and return to their homes confront substantial health challenges and an unpredictable future. While understanding of the unique needs of COVID-19 survivors is developing, components of the evidence-based Transitional Care Model provide a framework for taking a more immediate, holistic response to caring for these individuals as they moved back into the community. These components include: increasing screening, building trusting relationships, improving patient engagement, promoting collaboration across care teams, undertaking symptom management, increasing family caregiver care/education, coordinating health and social services, and improving care continuity. Evidence generated from rigorous testing of these components reveal the need for federal and state policy solutions to support the following: employment/redeployment of nurses, social workers, and community health workers; training and reimbursement of family caregivers; widespread access to research-based transitional care tools; and coordinated local efforts to address structural barriers to effective transitions. Immediate action on these policy options is necessary to more effectively address the complex issues facing these older adults and their family caregivers who are counting on our care system for essential support."],"journal":"J Aging Soc Policy","authors":["Naylor, Mary D","Hirschman, Karen B","McCauley, Kathleen"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32476586","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1080/08959420.2020.1773189","keywords":["covid-19","transitional care","family caregivers","older adults"],"topics":["Prevention"],"weight":1,"_version_":1668437835145805825,"score":59.589096},{"pmid":32274617,"title":"SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes.","text":["SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes.","SARS-CoV-2 virus, the causative agent of the coronavirus infectious disease-19 (COVID-19), is taking the globe by storm, approaching 500,000 confirmed cases and over 21,000 deaths as of March 25, 2020. While under control in some affected Asian countries (Taiwan, Singapore, Vietnam), the virus demonstrated an exponential phase of infectivity in several large countries (China in late January and February and many European countries and the USA in March), with cases exploding by 30-50,000/day in the third and fourth weeks of March, 2020. SARS-CoV-2 has proven to be particularly deadly to older adults and those with certain underlying medical conditions, many of whom are of advanced age. Here, we briefly review the virus, its structure and evolution, epidemiology and pathogenesis, immunogenicity and immune, and clinical response in older adults, using available knowledge on SARS-CoV-2 and its highly pathogenic relatives MERS-CoV and SARS-CoV-1. We conclude by discussing clinical and basic science approaches to protect older adults against this disease.","Geroscience","Nikolich-Zugich, Janko","Knox, Kenneth S","Rios, Carlos Tafich","Natt, Bhupinder","Bhattacharya, Deepta","Fain, Mindy J","32274617"],"abstract":["SARS-CoV-2 virus, the causative agent of the coronavirus infectious disease-19 (COVID-19), is taking the globe by storm, approaching 500,000 confirmed cases and over 21,000 deaths as of March 25, 2020. While under control in some affected Asian countries (Taiwan, Singapore, Vietnam), the virus demonstrated an exponential phase of infectivity in several large countries (China in late January and February and many European countries and the USA in March), with cases exploding by 30-50,000/day in the third and fourth weeks of March, 2020. SARS-CoV-2 has proven to be particularly deadly to older adults and those with certain underlying medical conditions, many of whom are of advanced age. Here, we briefly review the virus, its structure and evolution, epidemiology and pathogenesis, immunogenicity and immune, and clinical response in older adults, using available knowledge on SARS-CoV-2 and its highly pathogenic relatives MERS-CoV and SARS-CoV-1. We conclude by discussing clinical and basic science approaches to protect older adults against this disease."],"journal":"Geroscience","authors":["Nikolich-Zugich, Janko","Knox, Kenneth S","Rios, Carlos Tafich","Natt, Bhupinder","Bhattacharya, Deepta","Fain, Mindy J"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32274617","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s11357-020-00186-0","keywords":["covid-19","care","immunity","older adults","pathogenesis","sars-cov-2"],"link_erratum_in":"32363428","locations":["China","Singapore","Vietnam","China","USA"],"countries":["Viet Nam","China","Singapore","United States"],"countries_codes":["VNM|Viet Nam","CHN|China","SGP|Singapore","USA|United States"],"topics":["Mechanism","Diagnosis","Treatment"],"weight":1,"_version_":1666138491674689539,"score":58.707714}]}